An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
Study found that prostate-specific antigen velocity has prognostic value in localised prostate cancer but that further research is needed to provide stronger evidence for the most promising prognostic markers for this type of cancer
1 The University of Sheffield, School of Health and Related Research (ScHARR), , UK
2 Royal Hallamshire Hospital, Glossop Road, Sheffield, UK
3 Manchester University, Christie Hospital and Salford Royal Hospital, Manchester, UK
4 Department of Clinical Oncology, Velindre Hospital, Cardiff, UK
* Corresponding author Email: p.a.sutcliffe@warwick.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document